Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2014

Jan 7, 2014

33819_dirs_2014-01-06_a3c74436-1212-477a-a8a6-7417e9abed07.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2013-12-20

Reporting Person: WEISSMAN IRVING (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-12-20 Common Stock A 643 $1.00 Acquired 151673 Direct
2014-01-03 Common Stock A 10163 $0.00 Acquired 161836 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 19012 Indirect

Footnotes

F1: The $1.00 per share price was the stock option exercise price for shares granted to Dr. Weissman on January 1, 2004.

F2: Includes anniversary equity grant of 10,000 restricted stock units, vesting 100% on October 1, 2014, the one year anniversary of the grant.

F3: Quarterly retainer paid to Dr. Weissman in shares of common stock as consideration for his continued service of the Company's Scientific Advisory Board.

F4: 10,508 shares held in trust as to which Dr. Weissman disclaims beneficial ownership.